Women's Health News

RSS

UTSA, UTHSCSA researchers to jointly develop next-generation breast cancer treatment drugs

Stanton McHardy, associate professor of chemistry and director of the Center for Innovative Drug Discovery in The University of Texas at San Antonio College of Sciences, is partnering on a $1.9 million award to develop next-generation breast cancer treatment drugs.

19 Dec 2014

Elekta's Flexitron brachytherapy afterloading platform approved in China

Elekta announces that the China Food and Drug Administration has approved Elekta's Flexitron brachytherapy afterloading platform for sale and marketing in China.

From Elekta 18 Dec 2014

Trophoblasts respond to inflammatory danger signals, find NTNU researchers

Trophoblasts, cells that form an outer layer around a fertilized egg and develop into the major part of the placenta, have now been shown to respond to inflammatory danger signals, researchers from Norwegian University of Science and Technology found in a recent study published in Journal of Reproductive Immunology December 2014.

18 Dec 2014

Inovio begins hTERT DNA immunotherapy trial in adults with breast, lung and pancreatic cancer

Inovio Pharmaceuticals, Inc. announced it has initiated a phase I trial of its hTERT DNA immunotherapy (INO-1400) alone or in combination with Inovio's IL-12 immune activator (INO-9012) in adults with breast, lung, or pancreatic cancer at high risk of relapse after surgery and other cancer treatments.

18 Dec 2014

Maternal exposure to fine particulate air pollution contributes to autism risk

Women exposed to high levels of fine particulate matter specifically during pregnancy--particularly during the third trimester--may face up to twice the risk of having a child with autism than mothers living in areas with low particulate matter, according to a new study from Harvard School of Public Health.

18 Dec 2014

Research outlines new model for measuring acceptability of contraceptive vaginal ring

The Population Council published new research in the November issue of the journal Contraception demonstrating that an investigational one-year contraceptive vaginal ring containing Nestorone and ethinyl estradiol was found to be highly acceptable among women enrolled in a Phase 3 clinical trial.

18 Dec 2014

Tel Aviv University study throws spotlight on gene mutation responsible for premature ovarian failure

Premature ovarian failure, also known as primary ovarian insufficiency (POI), affects 1% of all women worldwide. In most cases, the exact cause of the condition, which is often associated with infertility, is difficult to determine.

18 Dec 2014

New study identifies how SNAIL gene helps cancer cells break free from primary tumor

More than 90 percent of cancer-related deaths are caused by the spread of cancer cells from their primary tumor site to other areas of the body. A new study has identified how one important gene helps cancer cells break free from the primary tumor.

18 Dec 2014

Emerging evidence suggests electronic cigarettes can help smokers quit

New Cochrane review finds emerging evidence that smokers who use electronic cigarettes can stop or reduce their smoking.

17 Dec 2014

Investigational drug increases PFS in patients with advanced breast cancer

In a groundbreaking study that offers new hope for women with advanced breast cancer, researchers from UCLA's Jonsson Comprehensive Cancer Center have published final clinical trial results that showed the amount of time patients were on treatment without their cancer worsening (called progression-free survival) was effectively doubled in women with advanced breast cancer who took the experimental drug palbociclib.

17 Dec 2014

UVA study finds that measurement of breast density better predicts woman's breast cancer risk

A new study from UVA Cancer Center found that adding a measurement of breast density better predicts women's risk for breast cancer. Including breast density as part of risk models for breast cancer could support the development of a personalized risk model to recommend how often a woman should have a mammogram based on her unique risk factors.

17 Dec 2014

UTSA receives NIH grant to develop bioinformatics tools to find cause of breast cancer

According to the American Cancer Society, breast cancer is the most common cancer among American women, except for skin cancers, and about one in eight women in the United States will develop invasive breast cancer during their lifetime. The National Institutes of Health recently awarded a $1.08 million grant to The University of Texas at San Antonio to combine computational modeling with biological information to advance our understanding of what may cause breast cells to become cancerous.

16 Dec 2014

Lung cancer in women: an interview with Harold Wimmer and Chuck Brynelsen

We at the American Lung Association know that lung cancer is the number one cancer killer among women, however, there is a startling lack of information available to the public regarding lung cancer.

16 Dec 2014

Curie-Cancer, GamaMabs Pharma extend partnership to develop 3C23K drug for gynecological cancers

Curie-Cancer, the body responsible for developing Institut Curie’s industry partnership activities, and GamaMabs Pharma, a company specialized in the development of monoclonal antibodies for cancer, today announce the extension of their partnership to develop the 3C23K antibody for the treatment of gynecological cancers.

16 Dec 2014

Study provides rare evidence on effect of Iraq War on child marriage, early childbearing

A study published today is the first detailed assessment of whether the 8-year Iraq War had an effect on childbearing. The study found that before the war, from 1997 to 2003, adolescent fertility in Iraq was stable at just below 70 births per 1,000 girls aged 15-19.

16 Dec 2014

Trastuzumab drug improves long-term survival of patients with HER-2 positive breast cancer

VCU Massey Cancer Center physician-researcher Charles E. Geyer, Jr., M.D., was the National Protocol Officer for one component of a large national study involving two National Cancer Institute-supported clinical trials that demonstrated that trastuzumab significantly improves the long-term survival of HER-2 positive breast cancer patients.

16 Dec 2014

Two-drug combination before surgery benefits women with triple-negative breast cancer

A breast cancer specialist and clinical researcher at Women & Infants Hospital of Rhode Island presented research yesterday at the 2014 San Antonio Breast Cancer Symposium showing that adding either the chemotherapy drug carboplatin or the blood vessel-targeting drug bevacizumab to the standard treatment of chemotherapy before surgery helped women who have the basal-like subtype of triple-negative breast cancer.

15 Dec 2014

Photoacoustic imaging has potential to be used as noninvasive method to detect cervical cancer

Cervical cancer is, in many ways, a shining example of how successful the war on cancer can be. Thanks largely to the advent of Pap smear screening, U.S. cervical cancer deaths decreased dramatically, by more than 60 percent, between 1955 and 1992. In the last two decades, better treatment outcomes and more powerful imaging techniques have steadily pushed 5-year survival rates ever higher.

15 Dec 2014

Oncotype DX assay linked to decrease in chemotherapy use in younger patients

In what's believed to be one of the largest population-based studies of Oncotype DX ever conducted, researchers at The University of Texas MD Anderson Cancer Center have found that the commercial diagnostic tool, Oncotype DX, was associated with a decrease in chemotherapy use in younger patients, but not in those over 66 years of age.

14 Dec 2014

New study analyses prevalence of domestic violence against pregnant women

A new study analyses the violent behaviours exhibited towards pregnant women. While 21% of women suffer emotional violence during pregnancy, 3.6% encounter physical or sexual violence. Furthermore, 36.1% of those who reported physical violence claimed that it happened "very often" or "daily".

14 Dec 2014

Women's Health News

UTSA, UTHSCSA researchers to jointly develop next-generation breast cancer treatment drugs

Elekta's Flexitron brachytherapy afterloading platform approved in China

Trophoblasts respond to inflammatory danger signals, find NTNU researchers

Inovio begins hTERT DNA immunotherapy trial in adults with breast, lung and pancreatic cancer

Maternal exposure to fine particulate air pollution contributes to autism risk

Research outlines new model for measuring acceptability of contraceptive vaginal ring

Tel Aviv University study throws spotlight on gene mutation responsible for premature ovarian failure

New study identifies how SNAIL gene helps cancer cells break free from primary tumor

Emerging evidence suggests electronic cigarettes can help smokers quit

Investigational drug increases PFS in patients with advanced breast cancer

UVA study finds that measurement of breast density better predicts woman's breast cancer risk

UTSA receives NIH grant to develop bioinformatics tools to find cause of breast cancer

Lung cancer in women: an interview with Harold Wimmer and Chuck Brynelsen

Curie-Cancer, GamaMabs Pharma extend partnership to develop 3C23K drug for gynecological cancers

Study provides rare evidence on effect of Iraq War on child marriage, early childbearing

Trastuzumab drug improves long-term survival of patients with HER-2 positive breast cancer

Two-drug combination before surgery benefits women with triple-negative breast cancer

Photoacoustic imaging has potential to be used as noninvasive method to detect cervical cancer

Oncotype DX assay linked to decrease in chemotherapy use in younger patients

New study analyses prevalence of domestic violence against pregnant women

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News